This Wednesday, our VP of technical operations, Justin Skoble, PhD, will present at the BioProcess International US West Conference. For more details and a full schedule, head to the event site: https://bit.ly/3X82jEI #BPIWest
Caribou Biosciences
生物技术研究
Berkeley，CA 37,899 位关注者
Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
关于我们
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.
- 网站
-
https://cariboubio.com
Caribou Biosciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Berkeley，CA
- 类型
- 上市公司
- 创立
- 2012
- 领域
- Next-generation CRISPR genome editing、allogeneic CAR-T cell therapies、oncology和autoimmune
地点
-
主要
获取路线
2929 7th St, Suite 105
US，CA，Berkeley，94710
Caribou Biosciences员工
动态
-
Our president and CEO Rachel Haurwitz, PhD, spoke with Biotech2050 about Caribou's recent progress, highlights from the J.P. Morgan Healthcare Conference, as well as what to expect from Caribou in 2025. Listen to the full conversation here:?https://lnkd.in/eyKRrJjV
?? CRISPR, CAR T, and the future of cell therapy—this episode of #Biotech2050 is a must-listen! Host Rahul Chaturvedi sits down with Rachel Haurwitz, President & CEO of Caribou Biosciences, to explore how CRISPR-based genome editing is transforming off-the-shelf CAR T therapies and what it means for cancer, autoimmune diseases, and beyond. ?? From early CRISPR research to leading Caribou’s four groundbreaking clinical trials, Rachel shares: ?? The promise of off-the-shelf CAR T cell therapy for lymphoma, multiple myeloma, and lupus ?? The challenges & opportunities in biotech funding, partnerships, and scaling innovation ?? Lessons from taking Caribou public and navigating a rapidly evolving biotech landscape ?? Why biotech leaders must stay laser-focused on what they do best ?? Whether you're a biotech entrepreneur, investor, or just fascinated by where gene editing is headed next, this conversation delivers powerful insights. ?? Tune in now! → https://lnkd.in/eyKRrJjV #CRISPR #Biotech #GeneEditing #CarT #CellTherapy #HealthcareInnovation #BiotechLeadership #Biotech2050
-
Caribou is uniquely positioned in H1 2025 with two clinical data milestones anticipated as we rapidly advance our off-the-shelf CAR-T cell therapies in development for oncology and autoimmune diseases. Read our fourth quarter and full year 2024 financial results and business update here: https://bit.ly/3Fk5GSQ
-
-
At Caribou, we’re proud to foster an environment that values the brilliant women on our team who are an integral part of #TheHerd. #InternationalWomensDay #WomenInSTEM
-
Happy #EmployeeAppreciationDay! We deeply appreciate our Caribou team, #TheHerd, filled with hard-working members dedicated to developing innovative, transformative therapies for patients with devastating diseases. We thank you today and every day for all that you do!
-
Heading to the Supply Chain & Logistics for Cell & Gene Therapies Summit? Our director of supply chain, Kevin Liao, will lead a workshop on #allogeneic cell source-specific supply chain requirements. For more details, visit: https://bit.ly/3EHT9It #celltherapy #supplychain
-
-
Don't miss Caribou's VP of medical affairs, Tonia Nesheiwat, PharmD, discussion on The Pharmaverse Podcast about her career journey.
?? ?????????????? ??: ?????????????????? ?????????????????????? ???????? ?????????? ????????????????????? ?????????????? ????????: https://lnkd.in/g_MimUgj In this episode of The Pharmaverse Podcast, our host Michael Pietrack interviews Tonia Nesheiwat, VP of Medical Affairs at Caribou Biosciences. They everything from baseball to and inspiring family journey to America. Together, they delve into Tonia's leadership style shaped by sports and family values. ?? ?? Tonia shares insights on the importance of mentorship, the challenges in medical affairs, and advice for aspiring leaders in the pharmaceutical industry. ?Tonia stresses the importance of working through issues when leading others, and keeping the eye on the ball as it relates to driving team success. ?? The conversation highlights the significance of hard work, the human element in leadership, and the need for continuous personal and professional growth. All the while, with a patients first mindset! ???????? ???? ?????? ?????????????? ?????????? ??????????????.????? ???????? ???? ??????????????????! Key Moments: ?????? Leadership traits are often instilled early in life. ???? Family sacrifices can shape one's work ethic and values. ? Sports can provide foundational leadership skills. ?? Competition should be with oneself, not others. ??Mentorship is crucial for personal and professional growth. ?? Effective communication is key in medical affairs. ?? Embrace opportunities outside of your comfort zone. ?? Education is a lifelong journey. ?? The pharmaceutical industry is competitive but offers niches. ??Leaders should focus on the human element of their teams. Chapters 00:00 Introduction to Leadership in Pharma 03:07 The Influence of Family on Leadership 06:02 Sports as a Foundation for Leadership 12:14 Navigating Challenges in Medical Affairs 20:45 Advice for Aspiring Leaders 24:52 The Human Element in Leadership
-
-
March is #MultipleMyeloma Awareness Month, raising awareness for a blood cancer that impacts thousands of people each year. Caribou has joined the fight against this devastating cancer through development of CB-011, an #allogeneic #CARTcelltherapy for the treatment of patients with relapsed or refractory multiple myeloma. Learn about our CaMMouflage trial: https://bit.ly/3TKg3Eb
-
-
If you missed our webcast at the H.C. Wainwright & Co., LLC 3rd Annual Cell Therapy Virtual Conference where our president and CEO Rachel Haurwitz, PhD, discussed our #CRISPR CAR-T #celltherapies, be sure to watch the replay here: https://bit.ly/3WJCFGe
-